FDA Approved: AIRSUPRA — Original Application (AstraZeneca Pharmaceuticals LP)

View source ↗

Summary

FDA approved AirSupra, an original-application inhaled therapy combining albuterol sulfate and budesonide for asthma, developed by AstraZeneca Pharmaceuticals L…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• AIRSUPRA (Albuterol sulfate and budesonide)
• Albuterol sulfate (Albuterol sulfate)
• Budesonide (BUDESONIDE)

Snippet

ORIG AP for AIRSUPRA (ALBUTEROL SULFATE AND BUDESONIDE)